Complex Wound Management With Negative Pressure Wound Therapy and an All‑In‑One Dressing

Medical disclaimer: This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always follow your local protocols and device instructions for use.

Why complex wounds and NPWT can be so frustrating

Negative pressure wound therapy (NPWT) is now a mainstay for complex wounds—especially diabetic foot ulcers, pressure injuries, and postoperative lower‑extremity wounds—because it promotes granulation, removes exudate, and can reduce amputation risk in people with diabetes. [1,3]

Despite its benefits, everyday use of NPWT is rarely “plug and play.” Clinicians routinely struggle with maintaining a seal around awkward anatomy, managing heavy drainage, preventing periwound maceration, and minimizing pain or skin stripping when the drape is removed. [1,2]

To address these issues, manufacturers have begun pairing NPWT with hybrid silicone‑acrylic drapes and extended‑wear, all‑in‑one dressings that aim to simplify application, protect fragile skin, and keep therapy running continuously. [5,7]

The case series “Complex Wound Management With Negative Pressure Wound Therapy and All‑In‑One Dressing (CS‑043)” evaluated one such peel‑and‑place dressing in three adults with complex wounds, focusing on application time, patient comfort, seal reliability, periwound skin condition, and wound progress. [11]

What is an all‑in‑one NPWT “peel‑and‑place” dressing?

Traditional NPWT typically uses separate pieces: reticulated foam cut to size plus a polyurethane drape that must be trimmed, window‑paned, and carefully taped to form an airtight seal—steps that can be time‑consuming and technique‑sensitive. [1]

The multilayer peel‑and‑place dressing (MPPD) used in this series is pre‑assembled: a foam interface, incorporated non‑adherent contact layer, and a hybrid silicone‑acrylic drape come as a single unit that is placed, smoothed, and connected to the pump. [7,11]

Hybrid silicone‑acrylic drapes are engineered to maintain seal strength while allowing repositioning and reducing pain and epidermal stripping at removal—features supported by small case series where periwound skin remained intact and patients reported less discomfort. [5,6]

Manufacturer bench and field data for the V.A.C.® Peel and Place Dressing (Solventum/3M) report average application times under two minutes and potential reductions in dressing‑change frequency compared with traditional foam‑plus‑drape configurations, which aligns with the experience reported in CS‑043. [7,8]

Case series at a glance: three high‑risk patients

Each photo here is a different patient. From left to right; diabetic foot ulcer (Patient A), stage 3 pressure injury on left buttock (Patient B) and surgical wounds on the plantar surface and lateral ankle of the left lower extremity (Patient C)

In CS‑043, three patients aged 56–63 presented with: a diabetic foot ulcer, a stage 3 pressure injury, and complex surgical wounds. All had significant comorbidities, including diabetes, prior transmetatarsal amputation, hypertension, peripheral vascular disease, and Charcot neuroarthropathy—exactly the population where NPWT is often used to avoid further dehiscence or amputation. [3,11]

The all‑in‑one dressing was applied directly to each wound, followed by NPWT initiation. Standard wear time was seven days, although one patient required changes every 3–4 days due to skin maceration and poor adherence to off‑loading, underscoring that device performance still depends on load management and moisture control. [2,11]

At each change, clinicians documented wound dimensions, granulation quality, seal integrity, periwound skin status, and patient‑reported pain with removal, providing a practical look at the dressing’s behavior in routine practice rather than a controlled trial setting. [11]

Application time, seal, and periwound skin: what changed?

Across all three patients, staff reported that full applications took two minutes or less, much faster than typical custom‑cut foam and drape builds, which often require repeated trimming, patching, and troubleshooting around curves or bony prominences. [7,11]

Dressing removal was described as painless in all cases, and the NPWT seal remained intact throughout therapy—mirroring prior hybrid‑drape case series where dressings could be repositioned without losing adhesion and periwound skin showed no irritation. [5,11]

Importantly, clinicians noted no periwound skin complications during the course of NPWT, which is notable because traditional acrylic drapes are well known to contribute to skin stripping, blistering, and dermatitis in fragile or edematous limbs. [6,11]

Healing outcomes in the three complex wounds

Diabetic foot ulcer of Patient A after 7 days of Negative Wound Pressure Therapy

The smallest wound—a diabetic foot ulcer—closed completely after just seven days of NPWT with the all‑in‑one dressing, consistent with the rapid closure sometimes seen in small, well‑vascularized DFUs treated with NPWT in randomized trials. [3,11]

In the stage 3 pressure injury and the complex surgical wounds, clinicians observed measurable wound size reduction and the development of robust, healthy granulation tissue during the treatment period, echoing RCT findings that NPWT improves granulation and shrinkage compared with wet‑to‑dry or standard moist wound care. [2,9]

While this is a small, uncontrolled series, its outcomes are directionally consistent with meta‑analyses showing that NPWT accelerates healing and reduces amputation risk in diabetic foot ulcers and other chronic wounds, suggesting that the all‑in‑one dressing preserved the core therapeutic benefits of NPWT. [3,4]

How this aligns with the broader NPWT evidence

Multiple systematic reviews and meta‑analyses now support NPWT as an effective adjunctive therapy for diabetic foot ulcers, pressure injuries, and other complex wounds, with pooled data showing faster wound closure and significantly fewer major and minor amputations compared with standard therapy. [3,4]

A randomized trial in stages 3–4 pressure injuries demonstrated that NPWT produced superior granulation tissue formation and wound size reduction versus wet‑to‑dry dressing, reinforcing its value for deep, exudative pressure ulcers—the kind represented in one of the CS‑043 patients. [2]

Meta‑analyses comparing NPWT with moist wound care in leg and foot ulcers similarly report better healing and can help justify NPWT in patients who have failed standard dressings, especially when combined with off‑loading, vascular optimization, and infection control. [9,10]

Hybrid silicone‑acrylic drapes and pre‑assembled dressings are newer, but early series show they can maintain seals over anatomically challenging sites while reducing periwound trauma—supporting the concept that device design tweaks can meaningfully impact both patient comfort and real‑world adherence. [5,6]

Practical lessons for clinicians from CS‑043

1. Simplified NPWT builds can save time. Pre‑assembled foam‑plus‑drape dressings appear to cut application time to roughly two minutes in this series, which may reduce staff burden and make NPWT more feasible in busy outpatient clinics or facilities with limited skilled staff. [7,11]

2. Periwound protection matters. The absence of periwound complications in these three patients matches the experience from hybrid‑drape case series and highlights the value of gentler adhesives for older adults, those on steroids or anticoagulants, and patients with chronic edema or fragile skin. [5,6]

3. Off‑loading and moisture control are still non‑negotiable. One patient required more frequent dressing changes due to maceration and poor adherence to off‑loading, emphasizing that even the best dressing cannot overcome poorly managed pressure, shear, or exudate. [2,11]

4. NPWT should remain part of a comprehensive care plan. The positive outcomes in this series occurred in the context of ongoing systemic optimization, infection management, and close follow‑up, consistent with guideline statements that NPWT is an adjunct—not a stand‑alone solution—for complex wounds. [1,10]

Limitations of the case series and research gaps

CS‑043 includes only three patients, with no control group, so we cannot attribute outcomes solely to the all‑in‑one dressing or calculate comparative effect sizes versus standard NPWT dressings. [11]

Selection bias is likely—these were patients in a specialized wound‑care setting with access to NPWT and advanced dressings—and follow‑up durations are not long enough to comment on long‑term recurrence, device‑related complications, or cost‑effectiveness. [4,11]

Larger, prospective comparative studies are needed to evaluate whether all‑in‑one hybrid‑drape systems truly reduce staff time, pain scores, and periwound complications—and whether these gains translate into shorter time‑to‑closure, fewer device interruptions, or lower total cost of care. [4,5]

Bottom line

For clinicians already using NPWT, the CS‑043 case series suggests that an all‑in‑one, peel‑and‑place dressing with a hybrid silicone‑acrylic drape can preserve the well‑documented healing benefits of NPWT while simplifying application and protecting fragile periwound skin. [3,7]

Though small, the series aligns with broader evidence that NPWT accelerates healing in diabetic foot ulcers, pressure injuries, and other complex wounds, and it reinforces how device design—especially drape technology—can meaningfully influence patient comfort, staff workload, and the likelihood of maintaining continuous therapy. [4,5]

Until larger comparative data are available, the practical takeaway is straightforward: when NPWT is indicated and your team is battling leaks, painful drape removals, or fragile skin, a pre‑assembled hybrid‑drape system is a reasonable, evidence‑supported option to consider as part of a comprehensive wound‑care plan. [6,11]

References

1. Capobianco CM, Zgonis T. An overview of negative pressure wound therapy for the lower extremity. Clin Podiatr Med Surg. 2009;26(4):619‑631.

2. Şahin E, Rizalar S, Özker E. Effectiveness of negative‑pressure wound therapy compared to wet‑dry dressing in pressure injuries. J Tissue Viability. 2022;31(1):164‑172.

3. Zhang N, Liu Y, Yan W, Liu F. The effect of negative pressure wound therapy on the outcome of diabetic foot ulcers: a meta‑analysis. Int Wound J. 2024;21(4):e14886.

4. Chen L, Xu Y, Huang Y, et al. A systematic review and meta‑analysis of efficacy and safety of negative pressure wound therapy for chronic wounds. Ann Palliat Med. 2021;10(10):10816‑10826. Annals of Palliative Medicine

5. Fernández LG, Ousey K, Lipsky BA, et al. Use of a novel silicone‑acrylic drape with negative pressure wound therapy in anatomically challenging wounds: a six‑patient case series. Int Wound J. 2020;17(6):1710‑1718.

6. Greenstein E, Moore N. Use of a novel silicone‑acrylic drape with negative pressure wound therapy in four patients with periwound skin breakdown. Wounds. 2021;33(11):E70–E76.

7. Solventum/3M. 3M™ V.A.C.® Peel and Place Dressing Kit – product guide. 2024.

8. Hospital News. The future of wound dressing: V.A.C.® Peel and Place Dressing simplifies negative pressure wound therapy. 2024. Hospital News

9. Wang N, Zeng Y, Chen Y, et al. Comparison of negative pressure wound therapy and moist wound care for leg and foot ulcers: a meta‑analysis. Int Wound J. 2022. Europe PMC

10. Moda Health. Negative Pressure Wound Therapy (NPWT) Medical Necessity Criteria. 2025. Moda Health

11. Greenstein E. Complex Wound Management With Negative Pressure Wound Therapy and All‑In‑One Dressing (CS‑043). Case series/poster, Essentia Health; 2025.